GUGGENHEIM CAPITAL LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 94 filers reported holding HERON THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.27 and the average weighting 0.8%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$67,808
-50.5%
27,123
-16.2%
0.00%0.0%
Q3 2022$137,000
-19.4%
32,383
-46.9%
0.00%0.0%
Q2 2022$170,000
-54.8%
60,970
-7.5%
0.00%
-50.0%
Q1 2022$376,000
-36.9%
65,888
+1.0%
0.00%
-33.3%
Q4 2021$596,000
-13.9%
65,225
+0.7%
0.00%
-25.0%
Q3 2021$692,000
-31.3%
64,772
-0.3%
0.00%
-33.3%
Q2 2021$1,008,000
+6.4%
64,954
+11.2%
0.01%0.0%
Q1 2021$947,000
+32.6%
58,415
+73.1%
0.01%
+50.0%
Q4 2020$714,000
+123.1%
33,738
+56.5%
0.00%
+100.0%
Q3 2020$320,000
-81.8%
21,564
-77.3%
0.00%
-85.7%
Q3 2019$1,755,000
-13.7%
94,895
-13.3%
0.01%
-17.6%
Q2 2019$2,034,000
-26.4%
109,451
-3.2%
0.02%
-26.1%
Q1 2019$2,764,000
+5.1%
113,116
+11.6%
0.02%
+4.5%
Q4 2018$2,630,000
+1208.5%
101,394
+1500.3%
0.02%
+2100.0%
Q3 2018$201,000
-91.3%
6,336
-95.6%
0.00%
-80.0%
Q3 2017$2,322,000
+43.0%
143,840
+22.7%
0.01%
+25.0%
Q2 2017$1,624,000
-3.5%
117,183
+4.5%
0.00%
-20.0%
Q1 2017$1,683,000
+25.9%
112,108
+9.8%
0.01%
+25.0%
Q4 2016$1,337,000
-16.3%
102,069
+10.1%
0.00%
-20.0%
Q3 2016$1,598,000
-10.0%
92,730
-5.7%
0.01%
-16.7%
Q2 2016$1,776,000
-10.6%
98,382
-6.0%
0.01%0.0%
Q1 2016$1,987,000
-11.6%
104,617
+24.2%
0.01%
-14.3%
Q4 2015$2,249,000
+90.6%
84,220
+74.1%
0.01%
+75.0%
Q3 2015$1,180,00048,3720.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders